Quinoric

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Quinoric

Property Description
Active ingredient Hydroxychloroquine sulfate
Form Oral film-coated tablet
Pharmacological class Disease-Modifying Antirheumatic Drug (DMARD)
Common use Management of autoimmune diseases; antimalarial
Origin Synthetic compound

What Type of Medicine is Quinoric and What is its Composition?

Quinoric is a prescription-only pharmaceutical preparation supplied for oral administration as a film-coated tablet, containing Hydroxychloroquine sulfate as its single active ingredient. The drug is classified as both an Antimalarial agent and a Disease-Modifying Antirheumatic Drug (DMARD), placing it in the broader category of immunosuppressants. This classification reflects its use in the long-term management of chronic inflammatory conditions, helping to reduce the severity of disease flare-ups.

This compound is a synthetic derivative of the 4-aminoquinoline chemical family, manufactured through a controlled process to ensure high consistency. The final dosage form consists of the active drug integrated with necessary pharmaceutical excipients.


What is the General Purpose of Hydroxychloroquine Treatment?

The general purpose of treatment with Hydroxychloroquine is to control chronic inflammation and mitigate disease activity in certain systemic illnesses. Its dual classification reflects its application in two main areas: first, as an agent for the prevention and treatment of specific malarial infection, and second, as an immunosuppressant used to address the underlying processes of autoimmune diseases. Hydroxychloroquine plays a role in the long-term management of conditions like systemic lupus erythematosus and rheumatoid arthritis. Its action is systemic and aimed at modifying the core disease processes, which is essential for managing persistent chronic symptoms rather than just providing temporary relief.


Quinoric vs. Related Drug Classes

Quinoric is a specific brand of Hydroxychloroquine sulfate that functions as a DMARD, meaning its action is centered on sustained disease modification, which distinguishes it from common non-steroidal anti-inflammatory drugs (NSAIDs) used only for immediate symptom relief. While chemically related to Chloroquine, Hydroxychloroquine features a modification in its structure that influences its systemic profile. The medication is a single active ingredient product, ensuring that its systemic effects are focused exclusively on the known actions of Hydroxychloroquine, making it a foundational element in managing specific chronic, systemic conditions.

Regulatory References

  1. MedlinePlus Drug Information on Hydroxychloroquine

What side effects are possible with Quinoric?

Possible Side Effects and Safety Information

The official safety profile for Quinoric (Hydroxychloroquine sulfate) organizes potential adverse reactions according to the body system affected and the frequency of occurrence, based on regulatory documentation from authorities like the FDA and EMA.

System-Organ Classification and Frequency

Classification Examples (As documented in regulatory labels)
Common Adverse Reactions Gastrointestinal disturbances (nausea, vomiting, diarrhea, abdominal pain), headache, skin rash, and pruritus.
Ocular Disorders Corneal changes, visual disturbances, and the potential for irreversible retinopathy.
Cardiac Disorders Cardiomyopathy (sometimes life-threatening) and ventricular arrhythmias, including QT prolongation.
Psychiatric/Nervous System Dizziness, seizures, neuropathy, and, rarely, psychosis, depression, and suicidal behavior.

Serious and Duration-Related Safety Concerns

The most clinically significant adverse reactions explicitly documented in official labeling involve the eyes and the heart. The risk of retinopathy is specifically noted as being related to the cumulative dosage and duration of use, with the risk increasing with long-term exposure. Cardiac compromise, including potentially fatal cardiomyopathy and severe arrhythmias, has been documented during both acute and chronic use. Severe hypoglycemia and serious cutaneous adverse reactions (e.g., Stevens-Johnson Syndrome) are also cited as rare but serious safety concerns.


Population-Specific Safety Notes

Official regulatory documents require caution for use in patients with hepatic or renal impairment due to the potential for increased toxicity. Specific visual field monitoring recommendations are documented for certain populations, such as individuals of Asian descent. The medication is contraindicated in patients with a known hypersensitivity to 4-aminoquinoline compounds.

Overdose and Emergency Response

Overdose and When to Seek Help

Regulatory documents define the overdose profile of Quinoric (Hydroxychloroquine sulfate) as a medical emergency due to the potential for rapid onset of severe, life-threatening toxicity, often presenting within 30 minutes to 3 hours following acute ingestion.

Immediate Emergency Actions

It is officially mandated to seek immediate medical attention and contact emergency services immediately upon any suspected overdose. Immediate transfer to a hospital is required for intensive care monitoring due to the high risk of rapid clinical deterioration, including the potential for cardiac arrest and cardiovascular collapse.

Documented Clinical Manifestations

Overdose toxicity primarily affects the cardiovascular and central nervous systems. Documented signs include severe hypotension, cardiac arrhythmias (such as QRS widening and ventricular fibrillation), and cardiovascular collapse. Central nervous system effects include seizures, loss of consciousness, and coma. In children, overdose is explicitly documented as highly toxic and potentially fatal, even at relatively small doses, necessitating strict control over access.

Management and Monitoring

Management is based on symptomatic and supportive treatment, as regulatory documents state that no specific antidote is known. Procedures documented in official prescribing information include gastric lavage, administration of activated charcoal to limit absorption, and necessary measures for seizure control. Continuous cardiac monitoring and serum electrolyte monitoring are required during the observation period.

Therapeutic Uses of Quinoric

Quinoric (Hydroxychloroquine sulfate) is commonly used as part of management in two distinct therapeutic domains: the long-term management of chronic autoimmune diseases and the management of susceptible malarial infections. These therapeutic areas represent the primary indications for the active ingredient.


What Quinoric Treats: Main Uses and Benefits

The medication is commonly considered relevant for supporting the long-term stabilization of chronic autoimmune conditions, specifically Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA). It is applied when conditions are characterized by periods of heightened symptoms, such as pronounced joint swelling, stiffness, and pain. It may also assist with managing certain systemic manifestations, like skin lesions in discoid lupus. In the infectious disease domain, it is relevant for both prophylaxis (prevention) of malaria and the treatment of uncomplicated acute infections caused by susceptible Plasmodium species. This therapeutic use generally contributes to easing the overall symptom load and supporting patients during episodes of heightened discomfort.


“This medication is applied in clinical settings that involve chronic, fluctuating symptom patterns where supportive symptom management is appropriate to assist with functional stability.”


Quick Fact: Symptom Management
Quinoric is commonly used to help manage persistent systemic inflammation and articular symptoms that interfere with daily functioning, assisting with day-to-day comfort during symptomatic periods.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Quinoric (hydroxychloroquine sulfate) eligibility is strictly defined by regulatory documents based on population and pre-existing health conditions.

The medicine is contraindicated and must not be used by individuals with known hypersensitivity to 4-aminoquinoline compounds or those with pre-existing maculopathy or retinal damage.

For approved uses in autoimmune diseases and malaria, the medicine is used in adults and pediatric patients. However, the tablet formulation is not recommended for children weighing less than 23 kg.

Use requires specific caution and monitoring in patients with certain comorbidities. These include pre-existing hepatic or renal impairment, cardiac risk factors like QT prolongation, G6PD deficiency, and conditions such as psoriasis or porphyria, which may be exacerbated. Use in older adults also requires caution due to the increased probability of age-related organ issues.

Regarding Reproductive Status, use during pregnancy is permitted only when the potential benefit to the mother outweighs the risk to the fetus. The medication is generally considered acceptable for use while breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Quinoric (hydroxychloroquine sulfate) defines several constraints and interaction classifications with co-administered products.


Interaction Restrictions and Timing Rules

Combinations with drugs known to prolong the QT interval are restricted due to the potential for additive effects on the heart's electrical activity. Co-administration with Halofantrine is not permitted, and concurrent use with Macrolide Antibiotics (such as Azithromycin) is associated with an increased risk of severe cardiovascular events. Use with Tamoxifen is not recommended due to a documented higher risk of retinal toxicity. A mandatory four-hour interval must be observed when taking Quinoric with antacids or Kaolin to prevent interference with the absorption of the medicine.


Exposure and Pharmacodynamic Effects

Quinoric is documented to influence the systemic concentration and effects of various medicines. The plasma levels of narrow-therapeutic-index drugs such as Digoxin and Cyclosporine may increase when co-administered, requiring monitoring. In the context of antidiabetic drugs (including Insulin), Quinoric may enhance the hypoglycaemic effect. The activity of antiepileptic drugs might be impaired, and co-administration with other drugs that lower the seizure threshold may increase the risk of convulsions. Certain antibiotics, such as Aminoglycosides, may also potentiate effects at the neuromuscular junction.

Mechanism of Action

How Quinoric Works

Quinoric (hydroxychloroquine) is an aminoquinoline compound that exerts its action across multiple biological domains, primarily through intracellular pH modulation. As a weak base, it accumulates selectively within acidic organelles, such as endosomes and lysosomes. This accumulation increases the organellar pH, disrupting the pH-dependent processing of proteins and molecules.

This core mechanism leads to two principal effects:

  1. Restriction of Antigen Presentation: The elevated endosomal pH inhibits the assembly of Major Histocompatibility Complex (MHC) class II proteins with processed autoantigens in antigen-presenting cells. This interference restricts the engagement of specific T-cell populations.

  2. Suppression of Pattern Recognition Receptors: Quinoric also modulates innate immunity by suppressing the activation of endosomal Toll-like receptors (TLRs), specifically TLR7 and TLR9. Blocking this signaling cascade reduces the expression of interferon-regulated genes and the subsequent release of pro-inflammatory cytokines, resulting in the reduction of overall pathway activity.

Dosage and Administration Information

How Quinoric (Hydroxychloroquine Sulfate) is Used

Quinoric is provided as an oral film-coated tablet, and its administration schedule is strictly determined by the specific condition being addressed. The official use protocol requires the medication to be taken with a meal or milk to aid absorption and reduce potential gastrointestinal irritation. The total daily dose for chronic use is procedurally limited by a maximum based on the patient's actual body weight.


Official Administration Schedules

Use Context Dosing Regimen Frequency & Duration Pattern
Chronic Autoimmune Disease (RA/SLE) Initial adult dose: 400 mg to 600 mg daily, followed by a maintenance dose of 200 mg to 400 mg daily. Taken daily; the full therapeutic effect is cumulative, requiring weeks to months.
Malaria Prophylaxis (Prevention) 400 mg dose. Taken once weekly, beginning two weeks before travel and continuing for four full weeks after leaving the area.
Acute Malaria Treatment Total of 2000 mg over 48 hours, beginning with an 800 mg dose. A compressed schedule of four doses staggered over a two-day period.

Procedural and Handling Instructions

The tablets are generally intended to be swallowed whole and should not be crushed or divided, as stated in the administration guidelines for the dosage form. The official administration protocol for pediatric patients (ge 31 kg) in the context of malaria is calculated based on 6.5 mg per kg of body weight. The overall use is structured to shift between long-term daily intake for chronic management and short-term, time-bound schedules for infectious disease contexts.

Recent Clinical Evidence

Research evidence / Overview of studies for Quinoric

Evidence for use in Systemic Lupus Erythematosus (SLE) and Discoid Lupus (CDLE)

The research exploring Quinoric for systemic lupus erythematosus (SLE) is built upon several types of research, including randomized controlled trials (RCTs) and larger, extensive long-term observational cohort studies. Researchers designed these studies to examine the data regarding key health outcomes, such as long-term patient survival, the frequency of disease flare-ups, and the progression of cumulative organ damage.

Studies described patterns observed in the data related to measurements of long-term survival metrics in observed populations with SLE. Research has explored and highlighted measurements concerning changes in the incidence of disease flares and patterns of cumulative organ damage over extended periods of time.

Evidence for use in Rheumatoid Arthritis (RA)

The research for Quinoric in rheumatoid arthritis (RA) includes randomized controlled trials (RCTs) and various long-term observational studies that include comparisons to placebo or other disease-modifying therapies. These investigations were designed to examine disease progression, measure changes in physical discomfort (such as joint swelling and pain), and monitor functional activity levels over time.

Studies explored how symptoms evolved in the observed RA populations, noting measurements related to joint status and overall disease activity. Data show patterns related to changes observed in metrics of structural joint damage.

Evidence for Antimalarial Prophylaxis and Treatment

Research exploring Quinoric for malaria treatment and prevention is historically established, consisting of classic efficacy trials, epidemiological studies, and continuous surveillance programs. These studies were conducted to examine two primary outcomes: the clearance of parasites from the bloodstream (for treatment) and the evaluated rates of infection prevention (for prophylaxis). The data consistently reported measurements of parasite suppression and evaluated rates of infection prevention when used against susceptible strains.

Areas of Research Uncertainty and Study Limitations

The scientific research structure for Quinoric, like all medications, is accompanied by research limitations and areas where certainty remains low. The requirement for sustained follow-up over several months before observed changes can be reliably measured is a factor that influences study design and follow-up duration. Furthermore, research highlights that the geographic variability of observed parasite suppression is a critical consideration due to increasing drug resistance in various Plasmodium strains.

Key Studies & References Hydroxychloroquine (Oral Route) - MedlinePlus Drug Information (National Institutes of Health)

Frequently Asked Questions (FAQ)

Common questions about Quinoric (FAQ)


Q: Does Quinoric start working right away, or is there a delay?

Official product information describes the effect as cumulative. The full therapeutic benefit for chronic conditions, such as rheumatoid arthritis or lupus, requires a delay of several weeks to months of use over time before the full benefit is typically observed.


Q: Are the vision changes associated with Quinoric permanent?

The most severe eye damage, known as retinopathy, is generally irreversible. Retinopathy has been noted to potentially progress after treatment cessation. However, official information suggests that other, less severe visual disturbances or corneal changes may be reversible upon discontinuation.


Q: Can Quinoric cause mood swings or anxiety?

Yes, regulatory documents note potential psychiatric side effects. These can include changes like affect/emotional lability (mood changes), nervousness, and in rare instances, severe conditions like psychosis or suicidal behavior.


Q: Can Quinoric be taken by people with a history of seizures?

Official documents describe a need for caution when used by people with a history of seizures. Regulatory data indicates that the medicine may impair the activity of antiepileptic drugs and may increase the risk of convulsions. The need for monitoring is described in regulatory documents if the drug is co-administered with antiepileptic drugs.


Q: Can vitamins and herbal supplements interfere with Quinoric?

Official product information describes the use of a four-hour interval when taking the medicine with antacids. This separation is necessary because antacids may interfere with the drug's absorption. Regulatory documents indicate that separation from supplements that may affect absorption, such as antacids, is required.


Q: Is Quinoric treatment typically lifelong?

The risk of irreversible retinal damage is related to the total amount and duration of use. The risk increases significantly after five years of chronic use. This highlights why close monitoring is part of the long-term use protocol described in official documents.


Q: Where does Quinoric fit in the treatment path for rheumatoid arthritis?

Official guidance classifies the medicine as a Disease-Modifying Antirheumatic Drug (DMARD). The drug is described as working to modify the underlying disease processes, reducing inflammation and helping to prevent long-term joint damage.


Q: Has Quinoric been researched for any other conditions besides its main uses?

Studies and official information indicate that researchers are considering the drug for new applications. These exploratory areas include conditions such as diabetes mellitus, certain heart diseases, and its potential use as an adjunct cancer therapy.


Q: Are there different versions or strengths of Quinoric available?

The product is officially supplied as an oral film-coated tablet. This tablet contains 200 mg of the active ingredient, hydroxychloroquine sulfate.


Q: Is it normal to have mild nausea when first starting Quinoric?

Gastrointestinal disturbances like nausea are listed in regulatory documents as very common adverse reactions. Regulatory information notes that gastrointestinal side effects are common, and the administration protocol specifies taking the tablet with a meal or milk.


Q: How often do the eye-related side effects occur with Quinoric?

Studies show that the risk of irreversible retinal toxicity is relatively rare at dosages described in official prescribing information. However, the risk is highly correlated with the duration of use, with available data indicating that the incidence rises after five years of continuous therapy.


Q: What are the official recommendations for monitoring eyes while taking Quinoric?

Official guidelines describe the protocol for eye monitoring, which involves a full baseline screening exam soon after starting treatment. This is typically followed by annual monitoring after the first five years of continuous use, or earlier based on individual patient criteria.


Q: Does Quinoric cause weight gain or weight loss?

Regulatory documentation lists loss of appetite (anorexia) as a common side effect. Weight loss has also been noted as a potential post-marketing adverse event.


Q: Does Quinoric make people more sensitive to sunlight?

Yes, the drug is officially associated with photosensitivity, which means it can increase the skin's sensitivity to sunlight. This may result in a reaction similar to a severe sunburn.


Q: Does Quinoric interact with common pain relievers like ibuprofen?

While regulatory labels do not list a direct drug-to-drug interaction with ibuprofen, official documents describe the need for caution when co-administering any NSAIDs. This is due to the general risks associated with that class of medicine, such as gastrointestinal events.


Q: Is it safe to take Quinoric with commonly prescribed blood thinners?

Official data indicates that caution is necessary because hydroxychloroquine may potentially increase the blood levels of certain blood thinners. This pharmacological effect is associated with a potential for a higher risk of bleeding complications.


Q: Is it safe to drink alcohol in moderation while on Quinoric treatment?

While there is no known direct interaction between the medicine and alcohol in regulatory documents, alcohol consumption may worsen certain side effects. These overlapping effects include common issues like headaches, nausea, and dizziness.


Q: If I miss a dose of Quinoric, what is the general guidance?

General guidance described in official patient information states that a missed dose may be taken as soon as it is remembered. If it is close to the time for the next scheduled dose, the guidance is to skip the missed dose, and not take double or extra doses.


Q: What happens if Quinoric treatment is suddenly stopped?

The sudden cessation of the medication, particularly for chronic autoimmune conditions, is generally not described as a recommended course of action in safety protocols. Discontinuing the treatment may lead to a flare-up or worsening of the underlying disease symptoms.


Q: How long does Quinoric stay in the body after the last dose?

Pharmacokinetic data shows that the drug has a long terminal half-life of approximately 32 to 50 days. This means the medicine takes an extended period of time to be fully eliminated from the body after discontinuation.


Q: Does taking Quinoric at a specific time of day matter?

Regulatory instructions for chronic use generally advise that the total daily dose can be taken once daily or divided into two doses. Official product information does not specify a prioritization for morning versus evening intake.


Q: What is the shelf life of Quinoric tablets?

Official regulatory guidance notes that the medicine should not be used after the expiry date (EXP) printed on the package. Using expired medicine is associated with a potential risk of reduced effectiveness or unexpected effects.


Q: Can Quinoric cause changes to the color of hair or skin?

Yes, official safety documentation notes that the medicine can cause changes to pigmentation. Documented side effects include the darkening of the skin (hyperpigmentation) and bleaching or blanching of the hair color.


Q: What laboratory tests are required before starting Quinoric treatment?

In addition to the mandatory baseline eye exam, the protocol describes the need for a complete blood count (CBC) to be performed periodically. This type of testing is described in official documentation for patients undergoing prolonged therapy due to the potential for hematologic side effects.

How should Quinoric be stored and disposed of?

Storage Conditions

Quinoric (hydroxychloroquine sulfate) tablets must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F to 77 F), according to official labeling. Storage at temperatures outside this range, generally up to 30 C (86 F), may be permitted under specific conditions. To maintain product stability, the medicine must be protected from light and moisture by storing it in its original, tight, light-resistant container.

Handling and Disposal

It is a mandatory regulatory requirement to keep Quinoric out of the reach of children. Any unused or expired medicine must be disposed of in accordance with local requirements. Official guidance generally recommends utilizing drug take-back programs and advises against flushing the tablets down the toilet or sink, as this is not an approved disposal method for this medication.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Quinoric found in:

A-Z Index: